Lung cancer, Non small cell lung cancer (NSCLC)
Results
Phase 3
This trial compared ceritinib with chemotherapy for people with non small cell lung cancer who had already had chemotherapy and crizotinib. It was for people with ALK gene changes (ALK positive cancer).
This trial was open for people to join between 2013 and 2015, and the team published the results in 2017.
Recruitment start: 16 December 2013
Recruitment end: 13 October 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Samreen Ahmed
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Novartis
Last reviewed: 2 August 2020
CRUK internal database number: 11151
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
